Transcarent

Transcarent

Private
Denver, ColoradoHealthcare & Life Scienceshttps://www.transcarent.com

Last Round

Series D

5/2/2024

Est. Valuation

$2.2B

Total Funding Raised

$424M

Momentum Score

25 /100

Company Overview

Transcarent is a healthtech company that provides a consumer-directed health and care platform for employees of self-insured employers and their families.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Vertical SaaS, Telemedicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Subscription SaaS, Revenue Share, Marketplace Commission

AI Layer

Application

Keywords

health and care navigationdigital front doorself-insured employersvalue-based careemployee benefits platformat-risk modeltelehealth platformvirtual careshared savings modelAI health navigationbundled paymentsexpert medical opinionpharmacy benefitsPMPMsurgery careagentic AIbehavioral health care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Transcarent Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Transcarent Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D5/2/2024
Series C1/11/2022
Series B6/10/2021
Series A10/22/2020

Key People

Founding team and executive leadership

Glen Tullman

Chief Executive Officer

Executive Team

Stephanie Peng

Chief Financial Officer

Executive Team

Transcarent Investors

Notable investors and investment history

InvestorRounds
Human CapitalSeries D, Series C
GreatPoint VenturesSeries B
Geodesic CapitalSeries D
Threshold VenturesSeries C, Series B, Series D
Leaps by BayerSeries D
Ally Bridge GroupSeries C, Series D
M13Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 24, 2026

    Partnered with SmithRx to expand Pharmacy Care Experience.

  • Apr 20, 2026

    Reached 21 million members served.

Transcarent Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Transcarent Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Transcarent's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range640
Year Founded2020
Last Funding5/2/2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.